BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1069234)

  • 1. [Evaluation in children of the clinical, biological and electroencephalographic side effects of L-asparaginase].
    Olive D; Cartault F; Legras B; Neimann N
    Pediatrie; 1976 Apr; 31(3):259-78. PubMed ID: 1069234
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apropos of certain toxic effects of L-asparaginase in human therapy].
    Oberling F; Cazenave JP; Lang JM; Kurtz D; Mayer G; Waitz R
    Sem Hop; 1971 May; 47(22):1421-5. PubMed ID: 4326093
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute leukemia with the L-asparaginase. Preliminary results based on 84 cases].
    Bernard J; Jacquillat C; Boiron M; Weil M; Bussel A; Larrieu MJ; Delobel J; Goguel A; Levy D; Tanzer J
    Presse Med (1893); 1970 Jan; 78(4):161-6. PubMed ID: 5264814
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of acute leukemias in children. 2].
    Jacquillat C; Weil M; Schaison G; Delobel J; Bussel A; Brunel-Kotschi R; Gemon MF; Loisel JP
    Med Klin; 1972 Aug; 67(32):1040-5. PubMed ID: 4506878
    [No Abstract]   [Full Text] [Related]  

  • 8. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Onuma T; Rosner F; Levy RN; Cuttner J; Moon JH; Silver RT; Blom J; Falkson G; Burningham R; Glidewell O; Holland JF
    Cancer Chemother Rep; 1971 Jun; 55(3):269-75. PubMed ID: 5315678
    [No Abstract]   [Full Text] [Related]  

  • 10. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 11. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy.
    Weetman RM; Baehner RL
    Cancer; 1974 Sep; 34(3):780-5. PubMed ID: 4527863
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-Asparaginase in the treatment of acute leukemia].
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L; Schneider M
    Sem Hop; 1970 Apr; 46(17):1135-40. PubMed ID: 4315231
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of L-asparaginase in therapy with special reference to acute lymphatic leukemia].
    Storti E; Fontana G
    Minerva Med; 1972 Mar; 63(24):1445-56. PubMed ID: 4502507
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute leukemia with L-asparaginase.
    Loeb E; Hill JM; Hill NO; MacLellan A; Khan A; Alexander TR; Adachi A
    Recent Results Cancer Res; 1970; 33():204-18. PubMed ID: 5292717
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR; Henderson E
    Cancer; 1971 Jun; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
    Jacquillat C; Weil M; Bussel A; Loisel JP; Rouesse T; Larrieu MJ; Boiron M; Dreyfus B; Bernard J
    Recent Results Cancer Res; 1970; 33():263-78. PubMed ID: 5292720
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 18. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adverse reactions associated with the use of L-asparaginase during therapy of patients with nB non-Hodgkin's lymphoma. Report of the Polish Paediatric LeuKaemia/Lymphoma Study Group].
    Wróbel G; Dobaczewski G; Kazanowska B; Bogusławska-Jaworska J; Balwierz W; Balcerska A; Bubała H; Dluzniewska A; Kołecki P; Kowalczyk J; Kurylak A; Maciejka-Kapuscinska L; Matysiak M; Rokicka-Milewska R; Sońta-Jakimczyk D; Sopyło B; Stefaniak MJ; Stefańska K; Stańczak E; Wysocki M
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):67-72. PubMed ID: 12021464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia.
    Leventhal BG; Skeel RT; Yankee RA; Henderson ES
    Cancer Chemother Rep; 1970 Feb; 54(1):47-51. PubMed ID: 4945997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.